FlowPoint Partners’ Opportunities Fund announces the acquisition of a 5% stake in tech start-up Puraclenz®
Peter DeCaprio & Grady Kittrell of FlowPoint Partners have made an investment of $1MM in Puraclenz®, whose patented line of ozone-free purifiers proactively deactivate viruses mid-air, at a fraction of the cost of traditional systems.
With our financial markets riveted lately by the action in GameStop (GME), attention has been turned to evil short sellers and getting shorty, which is natural. The action in GME was made more compelling by the breathless reporting in the media that it was so heavily shorted, with more than 100% of its float short, as if that were an issue (it wasn’t and it isn’t).
Every now and again, I come across someone I want to interview but they aren’t quite the right fit for MiB. Either the firm is too new or the assets too small or some other issue comes up.
That was the case with Chuck Trafton, a fund manager for FlowPoint Capital near Boston who I met years ago through John Roque. Trafton has been actively involved in Income Share Agreements (ISAs) through Purdue University, and now runs Edly, a marketplace for ISAs.